Automated Resupply Enrollment Now Available for HMEs Using Brightree and ResMed’s AirView
September 12 2017 - 6:00AM
Business Wire
HMEs applaud “huge time-saver” auto-enroll
feature
Managing compliance for sleep apnea patients and increasing
resupply revenue just got easier for home medical equipment (HME)
providers, as Brightree today announced automated resupply
enrollment for patients managed by both Brightree and AirView™ by
ResMed (NYSE: RMD).
Now when AirView alerts the Brightree® Connect resupply program
that a patient has achieved compliance on positive airway pressure
(PAP) therapy, the patient can be automatically enrolled into the
Connect resupply program, saving the HME time, increasing their
resupply revenue and most important, ensuring that every PAP user
is getting the best therapy experience possible. This feature is
available to HMEs that have integrated their Brightree Connect and
ResMed AirView accounts.
“This is a huge time-saver for us,” said Mindy Carlton, HME
business manager at Deaconess Home Medical in Evansville, Indiana.
“This kind of automation helps us grow our resupply business and
provide great patient care.”
Automated resupply enrollment is the latest in a growing list of
features for HMEs using Brightree and AirView, the world’s largest
remote monitoring network with more than 5 million patients. These
other features also aim to maximize both patient and HME
benefits:
- Automated data entry while registering
Brightree patients in AirView
- Automated invitation for patients to
sign up for myAir™, ResMed’s self-monitoring app that more than
1,250 new patients join every day
- Automated filing of AirView compliance
reports in Brightree Document Management
- Automated tasking when patients achieve
compliance
“Automation is the key to driving a smarter, faster healthcare
system and ultimately healthier patients,” said Matt Mellott,
Brightree president and CEO. “We’re excited to give HMEs the power
of automated resupply enrollment to increase their efficiency and
revenues, and most important, ensure that every patient gets the
supplies they need for the best possible therapy experience.”
About Brightree
Brightree, a wholly-owned subsidiary of ResMed (NYSE: RMD), is
the leading provider of cloud-based software to improve clinical
and business performance of post-acute care companies. Ranked one
of the top 100 healthcare IT companies in the U.S., Brightree
serves more than 2,200 organizations in the HME, home health,
hospice, orthotic and prosthetic, HME pharmacy, home infusion and
rehabilitation home care segments. For more information, visit
http://www.brightree.com or call 1.888.598.7797.
Brightree is a registered trademark of Brightree LLC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170912005503/en/
BrightreeFor media:Eric Lucey,
678-243-7986elucey@brightree.comorFor investors:Agnes Lee,
858-836-5971investorrelations@resmed.com
ResMed (NYSE:RMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
ResMed (NYSE:RMD)
Historical Stock Chart
From Apr 2023 to Apr 2024